Related by context. All words. (Click for frequent words.) 72 sentinel lymph node 72 micrometastasis 70 sentinel node 69 axillary nodes 68 sentinel nodes 68 micrometastases 68 precursor lesions 68 benign polyps 67 axillary lymph nodes 66 malignant lesions 66 mediastinal lymph nodes 66 lymph node metastases 66 histopathologic examination 66 occult metastases 66 lung nodules 65 underwent surgical resection 65 retroperitoneal 65 catheter angiography 65 sentinel lymph node biopsy 65 pelvic lymph nodes 65 renal cell carcinomas 65 nodal metastasis 65 pulmonary metastases 65 axilla 64 tumor biopsies 64 intestinal metaplasia 64 invasive carcinoma 64 Sentinel lymph node 64 malignant polyps 64 submucosal 64 adenoma 64 benign lesions 64 immunohistochemical staining 64 tissue biopsies 64 resected 64 ductal carcinomas 64 upper endoscopy 64 epithelial tumors 64 breast lesions 63 excisional biopsy 63 intraductal 63 esophagogastric junction 63 wedge resection 63 advanced adenomas 63 immunohistochemical 63 lung nodule 63 colorectal carcinoma 63 EUS FNA 63 contralateral breast 63 lung metastases 63 axillary dissection 63 FDG PET scans 63 mediastinal 63 lymph nodes 63 adenomatous polyps 63 thyroid nodules 63 liver resection 63 radical nephrectomy 63 tonsil tissue 63 peritoneal cancer 63 thymoma 62 underwent resection 62 transesophageal echocardiography 62 thyroglobulin 62 malignant nodules 62 breast carcinoma 62 mucinous 62 atypical hyperplasia 62 NMIBC 62 parathyroid 62 malignant prostate 62 precancers 62 nodal metastases 62 underarm lymph nodes 62 axillary lymph node dissection 62 core needle biopsy 62 metastatic lesions 62 hamartomas 62 biopsies 62 metastatic tumors 62 hamartoma 62 cervical lymph nodes 62 lymphadenectomy 62 breast carcinomas 62 PET CT scans 62 ductal 62 metastatic lymph nodes 62 colorectal neoplasms 62 proximal colon 62 helical CT 62 F FDG PET 62 axillary lymph node 62 carcinoid tumor 62 liver metastases 62 cancerous polyps 61 prostate cancer CaP 61 malignant ovarian 61 gadolinium enhanced 61 renal tumors 61 FDG-PET/CT 61 adenomatous 61 histologically 61 microcalcifications 61 fine needle aspiration 61 lymph node metastasis 61 metastases 61 transurethral resection 61 cytoreductive surgery 61 anal canal 61 prostate carcinoma 61 urothelial carcinoma 61 hyperplastic 61 benign nodules 61 situ LCIS 61 biopsy specimens 61 pancreatic adenocarcinoma 61 transabdominal 61 pathologic examination 61 FDG PET 61 endometrial carcinoma 61 thymectomy 61 heterotopic bone 61 neoplastic cells 61 SLNB 61 hypermethylated 61 para aortic 61 TRUS biopsy 61 malignant lesion 61 distant metastases 61 sentinel node biopsy 61 thyroid carcinoma 61 lymphatic tissue 61 biopsied tissue 61 peritoneal carcinomatosis 61 papillary renal cell carcinoma 60 advanced neoplasia 60 endoscopic retrograde cholangiopancreatography ERCGrant Parpan 60 urine cytology 60 sestamibi 60 pre cancerous polyps 60 neoplastic lesions 60 Sentinel node biopsy 60 colorectal adenocarcinoma 60 leiomyomas 60 precancerous polyp 60 immunohistochemical analysis 60 radiotracer 60 neuroblastoma tumors 60 digital subtraction angiography 60 transcranial Doppler 60 resectable 60 sonographically guided 60 needle aspiration 60 histologic examination 60 precancerous spots 60 transrectal ultrasound 60 malignant growths 60 SLN biopsy 60 cytological 60 pituitary adenomas 60 metastatic lesion 60 fibroadenoma 60 pT2 60 tunica vaginalis 60 positron emission 60 Cystoscopy 60 CIN2 + 60 tumoral 60 submandibular gland 60 DCIS lesions 60 node dissection 60 cancerous lesions 60 radioiodine therapy 60 pCR 60 pT3 60 pre malignant lesions 60 lobular carcinoma 60 prostate adenocarcinoma 60 GISTs 60 pelvic ultrasound 60 Immunohistochemical staining 60 arthrography 60 pelvic lymphadenectomy 60 thoracoscopic lobectomy 60 distant metastasis 60 #F FDG 60 core needle biopsies 60 renal pelvis 60 histological diagnosis 60 axillary 60 leiomyoma 60 percutaneous biopsy 60 ASCUS 60 FDG PET imaging 60 cystectomy 60 endoscopic resection 59 chromosomal mutations 59 premalignant 59 varices 59 HER2 expression 59 submandibular 59 pathologic diagnosis 59 positron emission tomography scan 59 Hurthle cell 59 fibroma 59 endometrial adenocarcinoma 59 lymph node 59 metastatic tumor 59 advanced adenoma 59 surgical biopsy 59 adenocarcinomas 59 biopsy specimen 59 Sentinel Lymph Node Biopsy 59 lymph gland 59 surgical biopsies 59 invasive carcinomas 59 adnexal masses 59 Fine needle aspiration 59 lymphovascular invasion 59 lung carcinomas 59 surgically resected 59 operable breast cancer 59 cytoreduction 59 extracapsular extension 59 lung biopsies 59 precancerous tissue 59 immunoblotting 59 mammographically 59 transrectal ultrasound guided 59 hydronephrosis 59 supratentorial 59 hepatectomy 59 miRview ™ squamous 59 squamous 59 mesenteric 59 resections 59 thyroidectomy 59 uterine cavity 59 undergone radical prostatectomy 59 cystic lesions 59 intraoperative complications 59 recurrent metastatic 59 polypectomy 59 transvaginal sonography 59 HG PIN 59 endoscopic ultrasound 59 sonographically 59 underwent radical prostatectomy 59 pigmented skin lesions 59 EBUS 59 squamous carcinoma 59 colonography 59 ALND 59 ultrasonographic 59 Histologically 59 FDG uptake 59 locoregional recurrence 59 immunostaining 59 pre cancerous lesion 59 somatic mutations 59 metachronous 59 polyps growths 59 dysplastic 59 papillary carcinoma 59 seminal vesicle 59 laser capture microdissection 59 lobectomies 59 histologic diagnosis 59 cisplatin resistant 59 prostate biopsy 59 prognostic biomarker 59 perfusion defects 59 lymphadenopathy 59 WT1 59 acute aortic dissection 59 intraluminal 59 malignant tissue 59 epithelial ovarian 59 B7 H3 59 Circulating tumor cells 59 Radical prostatectomy 59 axillary node dissection 59 microdissected 58 scintigraphic 58 biliary tree 58 endoscopically 58 lymph node dissection 58 lipomas 58 bladder prostate 58 syngeneic 58 appendiceal 58 cervical lymph node 58 invasive coronary angiography 58 parotid 58 lymphatic mapping 58 sonographic evaluation 58 Immunohistochemical analysis 58 pleomorphic 58 Papillary 58 node metastases 58 metastatic bladder 58 bone scintigraphy 58 colonoscopic 58 ascites fluid 58 BRAF mutation 58 colorectal polyp 58 spiral computed tomography 58 colorectal adenoma 58 chemoembolization 58 myxoma 58 mediastinum 58 Ductal carcinoma 58 seminal vesicles 58 schwannomas 58 conventional colonoscopy 58 ovarian malignancy 58 mesotheliomas 58 papillary 58 histological subtype 58 Lymph node 58 scintigraphy 58 paraffin embedded tissue 58 basal cell nevus syndrome 58 parenchyma 58 cystoscopic 58 malignant lymph nodes 58 lymph node involvement 58 breast biopsies 58 cystoscopy 58 biochemical relapse 58 transthoracic 58 Doppler echocardiography 58 arteriography 58 sonographic findings 58 gastric adenocarcinoma 58 cancerous nodules 58 curative resection 58 adventitia 58 submucosa 58 lymphocytosis 58 pulmonary nodules 58 debulking surgery 58 pleurodesis 58 pCLE 58 neoadjuvant chemotherapy 58 melanoma lesions 58 bronchogenic carcinoma 58 neoplasm 58 lymph node biopsy 58 ultrasound elastography 58 multidetector CT 58 TMPRSS2 ERG fusion 58 prostate cancer metastases 58 thyroid nodule 58 surgically resectable 58 ipsilateral breast 58 neurofibromas 58 pancreatic carcinoma 58 specific antigen PSA 58 endorectal coil 58 tumor excision 58 tissue microarray 58 adrenalectomy 58 jejunal 58 troponins 58 paragangliomas 58 noncancerous cells 58 meningiomas 58 colonic polyps 58 pleural fluid 58 Mohs micrographic surgery 58 EBUS FNA 58 cytologic 58 Her2/neu 58 Computed tomography 58 ischemic lesions 58 osteosarcomas 58 cerebral angiography 58 prostate TURP 58 microsatellite instability 58 hepatocellular carcinomas 58 pulmonary metastasis 58 osteoid osteoma 58 intraepithelial neoplasia 58 median sternotomy 57 ductal lavage 57 neoplasias 57 teratoma 57 bronchoalveolar lavage 57 basal cell skin 57 VATS lobectomy 57 nephrectomy 57 gated SPECT 57 epithelial ovarian cancer 57 pericardial effusion 57 computed tomographic scan 57 Biopsies 57 colon rectal 57 neoadjuvant therapy 57 mutated K ras 57 bisulfite sequencing 57 guided percutaneous 57 GSTP1 57 transitional cell carcinoma 57 coronary angiogram 57 coronary computed tomography 57 nonmelanoma skin cancers 57 stenoses 57 metaplasia 57 bioluminescence imaging 57 preoperative staging 57 abdominal lymph nodes 57 melanoma tumors 57 sCJD 57 opacification 57 bladder tumors 57 PCa 57 endoscopic retrograde 57 ductal cancer 57 recurrent glioblastoma multiforme 57 ProstaScint 57 neoplastic 57 repigmentation 57 angio 57 immunochemical 57 metastatic pancreatic 57 endobronchial 57 explants 57 lymphatics 57 Doppler sonography 57 precancer 57 guaiac 57 BRAF V#E mutation 57 leiomyosarcoma 57 coronary artery stenosis 57 intestinal polyps 57 hypervascular 57 biochemical recurrence 57 trophoblasts 57 Radiofrequency ablation 57 quantitative RT PCR 57 nodal dissection 57 cytologic examination 57 renal biopsy 57 engineered bladders 57 prophylactic cranial irradiation 57 atypical ductal hyperplasia 57 liver metastasis 57 Endometrial 57 carcinoembryonic antigen 57 tumor resection 57 ovarian carcinoma 57 intraoperatively 57 renal carcinoma 57 microdissection 57 surgical excision 57 HER2 amplification 57 duodenal 57 pheochromocytomas 57 superficial bladder cancer 57 plain radiographs 57 BRAF mutations 57 tumor recurrence 57 removed laparoscopically 57 diagnostic modality 57 lactate dehydrogenase 57 cerebrospinal fluid CSF 57 K ras mutations 57 polypoid 57 HGPIN 57 varicoceles 57 segmentectomy 57 laparoscopic cholecystectomy 57 chest radiographs 57 situ hybridization 57 stereotactic radiotherapy 57 malignant polyp 57 adjuvant radiation 57 fluorescein angiography 57 histological examination 57 urothelial 57 NSCLC tumors 57 stent stenosis 57 extracranial 57 urothelial cancer 57 endocervical 57 NP CRNs 57 lung tumors 57 carcinoids 57 digital rectal examination 57 grade cervical intraepithelial 57 biochemical marker 57 skeletal metastases 57 extrahepatic 57 gastric corpus 57 uveal melanoma 57 NMP# 57 sarcomatoid 57 precancerous lesion 57 oral squamous cell 57 lymphoid tissue 57 pre cancerous growths 57 needle biopsies 57 atypia 57 proximal femur 57 distal colon 57 normal karyotype 57 microdeletions 57 urethral stricture 57 perineural invasion 57 sonographic appearance 57 intravesical infusion therapy 57 needle biopsy 57 Lymph nodes 57 perfusion imaging 57 prostate carcinomas 57 computerized tomography scan 56 lung metastasis 56 node metastasis 56 premalignant lesions 56 TKAs 56 salpingo oophorectomy 56 differentiated thyroid 56 curable cancers 56 basal cell cancers 56 Figure 2C 56 biliary tract 56 ductal breast cancer 56 swollen lymph node 56 extracapsular 56 invasive lobular 56 coding genes 56 Histopathologic examination 56 extramedullary 56 MGUS 56 calculi 56 chemoresistant 56 underwent radical cystectomy 56 virulence genes 56 precancerous tumors 56 computed tomographic scans 56 OGG1 56 formalin fixed paraffin embedded 56 tracheobronchial 56 seminal vesicle invasion 56 endoscopic ultrasonography 56 pilocytic astrocytomas 56 osteoid 56 histologically proven 56 radionuclide imaging 56 retrospective cohort 56 TET2 56 PrPSc 56 HER2 gene 56 biopsy 56 APTIMA HPV 56 hematological relapse 56 nonmetastatic 56 intracavitary 56 histologic subtype 56 uterus fallopian tubes 56 coronary vasculature 56 keratoses 56 postoperative chemotherapy 56 noninvasive imaging 56 glandular tissue 56 ablating 56 tumors 56 tumorigenicity 56 Squamous 56 resection cavity 56 fluoroscopy guided 56 localized renal 56 hypervascular tumors 56 cytokeratin 56 Getzenberg 56 nodular lesions 56 prostate tissue 56 basal cell carcinoma BCC 56 TRUS 56 endometrial 56 postoperative morbidity 56 situ DCIS 56 carcinomas 56 intrahepatic 56 diagnose coronary artery 56 abdominal hysterectomy 56 lipoma 56 benign growths 56 stratifying patients 56 supraclavicular 56 coronary angiography 56 percutaneous drainage 56 radical prostatectomy RP 56 germline mutations 56 nephrectomies 56 PET CT scan 56 grade dysplasia 56 resected tumor 56 prostatic 56 chest radiography 56 allogeneic HSCT 56 pre cancerous lesions 56 ERCP 56 untreated metastatic melanoma 56 urography 56 histologically confirmed 56 preoperative MRI 56 skin sparing mastectomy 56 hypermethylation 56 squamous cell carcinoma SCC 56 pancreatic lung 56 histopathologic 56 cervical dysplasia 56 donor nephrectomy 56 radical cystectomy 56 cardiac magnetic resonance 56 spermatic cord 56 Positron emission tomography PET 56 antrum 56 total thyroidectomy 56 underwent prostate biopsy 56 precancerous condition 56 kidney cysts 56 methylation markers 56 posterior fossa 56 enucleation 56 peritumoral 56 colorectal liver metastases 56 IgA deficiency 56 DCIS ductal carcinoma 56 mCi 56 CT angiography CTA 56 breast MRIs 56 reimplantation 56 renal arteries 56 cutaneous melanoma 56 RALP 56 gastroduodenal 56 primary hyperparathyroidism 56 rebleeding 56 diagnostic biomarker 56 renal parenchyma 56 TIMP 56 cancerous lumps 56 histopathological examination 56 fallopian tube cancers 56 pseudotumor 56 LHRH receptor positive 56 immunohistochemistry 56 recurrent ovarian 56 KRAS oncogene 56 neuroendocrine cancers 56 polyp detection 56 cervicovaginal 56 splice junctions 56 ureteral stent 56 MDCT 56 hypoechoic 56 intraperitoneal chemotherapy 56 intrathoracic 56 #F FDG PET 56 RVOT 56 denervation 56 chromophobe 56 mitomycin C 56 carcinoma 56 lymph glands 56 Magnetic resonance 56 proto oncogene 56 ureteric 56 collagen VII 56 propria 56 N. gonorrhoeae 56 abdominal computed tomography 56 biopsy needle 56 ALA PDT 56 pre cancerous 56 artery embolization 56 immunohistochemistry IHC 56 grade squamous intraepithelial 56 nodule 56 sonographic 56 paraspinal muscles 56 ovarian tumors 56 preoperative diagnosis 56 penetrating keratoplasty 56 medically inoperable 56 lumpectomy cavity 56 clinically localized prostate 56 FISH fluorescence 56 amyloid deposits 56 keratoplasty 56 total abdominal hysterectomy 56 fibrocystic 56 neoadjuvant 56 vascular malformations 56 Surgical resection 56 radiofrequency ablation RFA 56 chemoradiotherapy 56 cardiac troponin T 55 endoscopist 55 hyperplastic polyps 55 DNA methylation markers 55 cTnI 55 oropharyngeal 55 spontaneous regression 55 detect polyps 55 Computed tomographic 55 PNET 55 transvaginal 55 serous ovarian cancer 55 sonographic examination 55 balloon angioplasties 55 lung resection 55 stage IIIA 55 pseudoaneurysm 55 CellSearch System 55 axillary node 55 invasive lobular carcinoma 55 anatomical landmarks 55 hyperintense lesions 55 inguinal hernia repair 55 squamous intraepithelial lesions 55 ultrasonographic examination 55 buffy coat 55 SUVmax 55 glandular tissues 55 myometrium 55 T#I [002] 55 MR spectroscopy 55 mediastinitis 55 HER2 positive tumors 55 lung biopsy 55 neoplasia 55 granulosa cell 55 hepatoma 55 histopathological 55 laparoscopies 55 Immunohistochemistry 55 ocular melanoma 55 Colon polyps 55 mediastinoscopy 55 sigmoid colon 55 esophageal carcinoma 55 malignant neoplasm 55 splenic 55 neoplasms 55 computed tomographic 55 lobular 55 leukapheresis 55 alkaline phosphatase ALP 55 Adjuvant therapy 55 angiosarcoma 55 thoracotomy 55 periosteal 55 pulmonary angiography 55 cancerous breast 55 mucosal lesions 55 SPINK1 55 RQ PCR 55 postoperative pathology 55 carcinoid 55 premalignant lesion 55 cervical carcinoma 55 embolisation 55 bronchogenic 55 endometrial biopsy 55 microbleeds 55 intra operatively 55 cell carcinomas 55 thrombi 55 CSF Tf 55 pretest probability 55 computerized axial tomography 55 endometrial biopsies 55 gene amplification 55 antral 55 differentially expressed proteins 55 Kaplan Meier analysis 55 carotid stenosis 55 angiographically 55 lymph node removal 55 BRCA deficient 55 armpit lymph nodes 55 Prostate Specific Antigen PSA 55 liver biopsies 55 myeloproliferative disorder 55 popliteal artery 55 recanalization 55 follicular thyroid cancer 55 squamous cells 55 fibroadenomas 55 liver parenchyma 55 CT perfusion 55 localized prostate 55 liposarcoma 55 TNF blocker therapy 55 nonsmall cell lung cancer 55 hyperacute 55 lobular breast cancer 55 metastatic liver 55 luminal 55 gene rearrangements 55 treat benign prostatic 55 tracer uptake 55 vascular anatomy 55 intra abdominal 55 coagulation parameters 55 cervical intraepithelial neoplasia 55 computerized tomography scans 55 p# mutation 55 Doppler ultrasonography 55 KRAS mutations 55 mucosal tissue 55 pelvic lymph node dissection 55 echogenic 55 PSA nadir 55 DEXA scans 55 renal cysts 55 HNSCC 55 brain parenchyma 55 endometrial hyperplasia 55 postoperative infection 55 HER2 positive cancers 55 invasive ductal 55 desmoid tumor 55 PITX2 55 GBM tumors 55 squamous cell lung cancer 55 FDDNP 55 CT colonography 55 esophagogastroduodenoscopy 55 malignant cancerous 55 benign moles 55 ovarian tumor 55 malignant tissues 55 cancerous tissue 55 transfusion syndrome 55 peritoneal 55 ductal adenocarcinoma 55 mesothelin 55 esophageal gastric 55 perfusion MRI 55 anal lesions 55 ureteroscopy 55 RT PCR assay 55 coronary blockages 55 lesions 55 radiographic examinations 55 uterine cervix 55 HER2 overexpression 55 RAS mutations 55 alveolar soft 55 Accelerated Partial Breast Irradiation 55 CT angiography 55 biochemical markers 55 carcinoma HNSCC 55 gastric carcinoma 55 metastatic gastric 55 distal esophagus 55 cytolytic activity 55 paracentesis 55 diagnostic angiography 55 TOP2A 55 laparoscopic nephrectomy 55 transrectal 55 hypointense 55 asymptomatic 55 computerized tomographic 55 lymphocytic 55 preoperative chemotherapy 55 dysplastic lesions 55 Cardiac catheterization 55 duplex ultrasonography 55 parenchymal 55 #F fluorodeoxyglucose 55 MUC1 protein 55 descending aorta 55 infraspinatus 55 malignant ascites 55 cancerous lesion 55 myocardial perfusion 55 choroidal 55 paraganglioma 55 egg follicles 55 chorionic villi 55 stage IIIB 55 BRCA1 BRCA2 55 metastatic malignant melanoma 55 colectomy 55 stomach duodenum 55 KRAS mutation 55 CIN3 + 55 trophoblast cells 55 cervical lesions 55 artery blockages 55 PSADT 55 abdominal incisions 55 florbetaben 55 radiochemotherapy 55 intracranial aneurysms 55 ovarian pancreatic 55 multicentric 55 inguinal 55 gastrectomy 55 molecular subtypes 55 cancerous lymph nodes 55 computed tomography scans 55 p# mutations 55 endoscopic ultrasound EUS 55 HER2 receptor 55 primitive neuroectodermal tumor 55 myogenic 55 microvessels 55 beta1 integrin 55 orthotopic 55 prion infection 55 FGFR2 gene 55 morphologic 55 urothelium 55 synovial sarcoma 55 BRCA2 mutation carriers 55 situ CIS 55 toluidine blue 55 prognostic indicator 55 pneumonectomy 55 adenomatous polyp 55 cancerous colon 55 limbal 54 x ray angiography 54 karyotyping 54 nutlin 3a 54 squamous cell cancers 54 histologic 54 intravesical therapy 54 transthyretin 54 telangiectasia 54 conventional angiography 54 osteolytic 54 endometrial tumors 54 sonographic guidance 54 variceal 54 GIST tumors 54 PTEN gene 54 virtual colonography 54 precancerous cervical 54 nomograms 54 cytogenetic abnormalities 54 venography 54 chromosomal aberrations 54 basilar 54 supernatants 54 locoregional 54 clinically detectable 54 contralateral 54 osteochondromas 54 IGF IR 54 chromosome #p#.# 54 colorectal gastric 54 sleeve lobectomy 54 fine needle aspirate 54 photon laser 54 malignant fibrous histiocytoma 54 adenomas 54 promoter methylation 54 extracolonic findings 54 cerebral angiogram 54 biliary tract cancer 54 pituitary adenoma 54 myofibroblasts 54 intra arterial 54 stromal 54 ovarian endometrial 54 bone marrow aspiration 54 synovial 54 CIN3 54 pretransplant 54 osteochondroma 54 Rosetta Genomics microRNA 54 serrated polyps 54 metastatic neuroendocrine tumors 54 transvaginal ultrasound 54 situ hybridisation 54 mammographic density 54 benign lesion 54 bowel resection 54 Hepatocellular Carcinoma HCC 54 preoperative evaluation 54 nonmelanoma 54 hilar 54 infiltrative 54 seminomas 54 benign proliferative breast 54 bladder ovarian 54 CT coronary angiography 54 lung pancreatic 54 IDH1 mutation 54 anogenital